Sanofi Said In Talks With Indian OTC Firm For Majority Stake
This article was originally published in PharmAsia News
Sanofi is reported negotiating with India's Universal Medicare to buy a majority share to increase its presence in the over-the-counter nutraceuticals business
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.